Shiting Zhang
Papers
3
Total Citations
12
H-Index
3
About
Shiting Zhang is a clinician-researcher specializing in head and neck oncology, with a particular focus on HPV-associated oropharyngeal cancer (OPC) and innovative surgical and immunotherapeutic treatment strategies. Zhang's work sits at the intersection of immuno-oncology and minimally invasive surgery, pioneering neoadjuvant approaches that combine anti-PD-1 immunotherapy with platinum-doublet chemotherapy prior to transoral robotic surgery (TORS). A central theme of Zhang's research is treatment de-escalation for HPV-positive oropharyngeal cancer — seeking to reduce the toxicity burden on patients who typically carry a more favorable prognosis than their HPV-negative counterparts. Zhang's most notable contributions include leading single-arm phase II trials evaluating neoadjuvant sintilimab combined with cisplatin and nab-paclitaxel, followed by transoral surgery, demonstrating promising major pathological response rates in resectable disease. These studies, accumulating early citations of up to 5, are already shaping clinical conversations around multimodal de-escalation strategies. Zhang has also contributed important prognostic analyses examining the interplay between HPV status and TORS outcomes. As a researcher advancing precision treatment paradigms for a cancer of growing global prevalence, Zhang represents an emerging voice in surgical oncology and translational head and neck cancer research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3